Atena Farkhondeh

Also affiliated with National Center for Advancing Translational Sciences

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Generation and characterization of NGLY1 patient-derived midbrain organoids”.

Generation and characterization of NGLY1 patient-derived midbrain organoids

Frontiers in Cell and Developmental Biology(2023)10.3389/fcell.2023.1039182

N/A

0.425DataRank · unranked

16 citations

Mitali A. Tambe, Ivan Pavlinov, Atena Farkhondeh, Ha Nam Nguyen, Miao Xu +7 more

Therapeutics Development for Alagille Syndrome

Frontiers in Pharmacology(2021)10.3389/fphar.2021.704586

N/A

0.406DataRank · unranked

14 citations

Atena Farkhondeh, Ivan Pavlinov, Karsten Baumgaertel, Steven Rodems, Wei Zheng +1 more

Generation of an induced pluripotent stem cell line (TRNDi031-A) from a patient with Alagille syndrome type 1 carrying a heterozygous p. C312X (c. 936 T > A) mutation in JAGGED-1

Stem Cell Research(2021)10.1016/j.scr.2021.102447

N/A

0DataRank · unranked

4 citations

Manisha Pradhan, Yu‐Shan Cheng, Kirill Gorshkov, Atena Farkhondeh, Catherine Z. Chen +6 more

Generation of Alagille syndrome derived induced pluripotent stem cell line carrying heterozygous mutation in the JAGGED-1 gene at splicing site (Chr20: 10,629,709C>A) before exon 11

Stem Cell Research(2021)10.1016/j.scr.2021.102366

N/A

0DataRank · unranked

3 citations

Yu‐Shan Cheng, Miao Xu, Atena Farkhondeh, Jeanette Beers, Jizhong Zou +5 more

Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9

Stem Cell Research(2021)10.1016/j.scr.2021.102554

N/A

0DataRank · unranked

3 citations

Atena Farkhondeh, Shu Yang, Miao Xu, Yu‐Shan Cheng, Jeanette Beers +7 more

An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene

Stem Cell Research(2021)10.1016/j.scr.2021.102400

N/A

0DataRank · unranked

1 citations

Atena Farkhondeh, Yu‐Shan Cheng, Miao Xu, Jeanette Beers, Jizhong Zou +6 more

Corrigendum to “Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9” [Stem Cell Res. 56 (2021) 102554]

Stem Cell Research(2021)10.1016/j.scr.2021.102602

N/A

0DataRank · unranked

0 citations

Atena Farkhondeh, Shu Yang, Miao Xu, Yu‐Shan Cheng, Jeanette Beers +7 more

An Induced Pluripotent Stem Cell‐Derived Neuromuscular Junction Platform for Study of the NGLY1‐Congenital Disorder of Deglycosylation

Advanced Therapeutics(2022)10.1002/adtp.202200009

N/A

0DataRank · unranked

2 citations

Ashley L. Robertson, Roxana Mendez, Tristan T. Hays, Ethan Smith, Helena B. Cooper +11 more

In depth characterization of midbrain organoids derived from wild type iPSC lines

PLoS ONE(2023)10.1371/journal.pone.0292926

N/A

0DataRank · unranked

8 citations

Mitali A. Tambe, Joshua M. Abbott, Ha Nam Nguyen, Miao Xu, Manisha Pradhan +3 more

High-throughput protein modification quantitation analysis using intact protein MRM and its application on hENGase inhibitor screening

Talanta(2021)10.1016/j.talanta.2021.122384

N/A

0DataRank · unranked

6 citations

Miao Xu, Atena Farkhondeh, Andrew P. Burns, Steven Rodems, Matthew Might +3 more